Literature DB >> 23424231

Metabolic impact of adding a thiazide diuretic to captopril.

Adam Whaley-Connell, James R Sowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23424231      PMCID： PMC3676883          DOI： 10.1161/HYPERTENSIONAHA.111.00494

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

Review 1.  Thiazide diuretics, potassium, and the development of diabetes: a quantitative review.

Authors:  Alan J Zillich; Jay Garg; Sanjib Basu; George L Bakris; Barry L Carter
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

2.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

3.  Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.

Authors:  James R Sowers; Leopoldo Raij; Ishwaral Jialal; Brent M Egan; Elizabeth O Ofili; Rita Samuel; Dion H Zappe; Das Purkayastha; Prakash C Deedwania
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

4.  Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension.

Authors:  S J Hunter; R Harper; C N Ennis; E Crothers; B Sheridan; G D Johnston; A B Atkinson; P M Bell
Journal:  J Hypertens       Date:  1998-01       Impact factor: 4.844

5.  Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertension.

Authors:  Claire M McHenry; A Brew Atkinson; Steven J Hunter; Jonathan N Browne; Cieran N Ennis; John S Henry; Brian Sheridan; Patrick M Bell
Journal:  Hypertension       Date:  2013-02-19       Impact factor: 10.190

6.  Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.

Authors:  Jan W Eriksson; Per-Anders Jansson; Bo Carlberg; Anders Hägg; Lisa Kurland; Maria K Svensson; Håkan Ahlström; Conny Ström; Lars Lönn; Kristina Ojbrandt; Lars Johansson; Lars Lind
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

7.  Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.

Authors:  Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Vincent G DeMarco; Rebecca Schneider; Susan D Sowers; Poorna Karuparthi; Carlos M Ferrario; James R Sowers
Journal:  Endocrinology       Date:  2008-07-24       Impact factor: 4.736

8.  Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Lucia Filippucci; Silvia Norgiolini; Costanza Bracco; Carlo Porcellati
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

9.  Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.

Authors:  Dion H Zappe; James R Sowers; Willa A Hsueh; Steven M Haffner; Prakash C Deedwania; Vivian A Fonseca; Lucy Keeling; Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-12       Impact factor: 3.738

10.  Improved early-phase insulin response after candesartan treatment in hypertensive patients with impaired glucose tolerance.

Authors:  Katsunori Suzuki; Osamu Nakagawa; Yoshifusa Aizawa
Journal:  Clin Exp Hypertens       Date:  2008-07       Impact factor: 1.749
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.